UCLA study: High-dose radiotherapy + chemo effective in treating NSCLC

Study: 50 million Americans live in counties without a radiation oncology clinic

More than 50 million Americans live in counties without a radiation oncology practice site and millions more are at risk, according to a study conducted by researchers at Icahn School of Medicine at Mount Sinai and Maimonides Medical Center.

July 17, 2026

Vol.52 No.28

In Brief

Northwell Cancer Institute opens $5.8M radiation center in Queens

The Northwell Cancer Institute announced the opening of its renovated Queens Radiation Center in Queens, New York City.

July 02, 2026

Vol.52 No.26

Clinical Roundup

Sigvotatug vedotin misses OS primary endpoint vs. docetaxel in phase III trial in previously treated metastatic non-squamous NSCLC

Sigvotatug vedotin, an integrin beta-6 directed antibody-drug conjugate, did not show a statistically significant improvement in the primary endpoint of overall survival, compared to docetaxel, according to the results of the phase III SigVie-002 study (previously known as Be6A Lung-01).

June 26, 2026

Vol.52 No.25

In Brief

UCLA researchers awarded $3.2M NIH grant to improve detection and treatment of glioblastoma

Researchers from the UCLA Jonsson Comprehensive Cancer Center have been awarded a $3.2 million grant from NIH to develop advanced imaging and surgical strategies aimed at improving outcomes for patients with glioblastoma, a fast-growing and aggressive brain tumor.

June 18, 2026

Vol.52 No.24

In Brief

UCLA researchers awarded $3.2M NIH grant to develop AI tool for more personalized liver cancer treatment

Jason Chiang and Kyung Sung of the Department of Radiological Sciences at the David Geffen School of Medicine at UCLA and the UCLA Health Jonsson Comprehensive Cancer Center have received a $3.2 million, five-year grant from NCI to develop an artificial intelligence-enhanced imaging platform designed to improve yttrium-90 (Y90) radioembolization planning for patients with liver cancer.

June 05, 2026

Vol.52 No.22

Clinical Roundup

Cytokine-armored CAR T-cell therapy helps eliminate aggressive brain tumors in UCLA preclinical study

Scientists at the UCLA Health Jonsson Comprehensive Cancer Center have developed a cytokine-armored CAR T-cell therapy that helps the immune system better attack aggressive brain tumors in mice while reducing dangerous side effects that have long limited immune-based treatments for glioblastoma, one of the deadliest and most treatment-resistant brain cancers.

May 29, 2026

Vol.52 No.21

UCLA study: High-dose radiotherapy + chemo effective in treating NSCLC

YOU MAY BE INTERESTED IN

Study: 50 million Americans live in counties without a radiation oncology clinic

Northwell Cancer Institute opens $5.8M radiation center in Queens

Sigvotatug vedotin misses OS primary endpoint vs. docetaxel in phase III trial in previously treated metastatic non-squamous NSCLC

UCLA researchers awarded $3.2M NIH grant to improve detection and treatment of glioblastoma

UCLA researchers awarded $3.2M NIH grant to develop AI tool for more personalized liver cancer treatment

Cytokine-armored CAR T-cell therapy helps eliminate aggressive brain tumors in UCLA preclinical study

Renew today!

Subscriber content

Never miss an issue!

Login